e-Edition
Obituaries
In Loving Memory
Magazines
Subscribe
Login to Comment
Register
jobs
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Life
Commentary
Contact
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
enGene Therapeutics Inc. - Common Stock
(NQ:
ENGN
)
1.500
-0.220 (-12.79%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 8, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
17,486,939
Open
1.710
Bid (Size)
1.490 (3,500)
Ask (Size)
1.500 (17,100)
Prev. Close
1.720
Today's Range
1.450 - 1.750
52wk Range
1.450 - 12.25
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
enGene Bladder Cancer Data Shows Promise, but Durability Questions Remain
↗
May 08, 2026
enGene (NASDAQ:ENGN) reported preliminary data from the pivotal Cohort 1 of its ongoing Phase 2 LEGEND trial evaluating detalimogene voroplasmide, or detalimogene, in patients with high-risk...
Via
MarketBeat
Which stocks are experiencing notable movement on Thursday?
↗
May 07, 2026
Via
Chartmill
Performance
YTD
-83.1%
-83.1%
1 Month
-79.5%
-79.5%
3 Month
-84.3%
-84.3%
6 Month
-75.2%
-75.2%
1 Year
-55.8%
-55.8%
More News
Read More
Top stock movements in today's session.
↗
May 07, 2026
Via
Chartmill
There are notable gap-ups and gap-downs in today's session.
↗
May 07, 2026
Via
Chartmill
Which stocks are moving before the opening bell on Thursday?
↗
May 07, 2026
Via
Chartmill
enGene Announces Updated Interim Results From LEGEND Pivotal Cohort
May 07, 2026
From
enGene Therapeutics Inc.
Via
Business Wire
enGene Announces Name Change to enGene Therapeutics Inc.
April 07, 2026
From
enGene Therapeutics Inc.
Via
Business Wire
This Biotech Was Quietly Bought Before a $58 Per Share Takeout
↗
March 21, 2026
Via
The Motley Fool
enGene Reports First Quarter 2026 Financial Results and Provides Business Update
March 09, 2026
From
enGene Holdings Inc.
Via
Business Wire
enGene to Participate in Upcoming Investor Conferences
February 20, 2026
From
enGene Holdings Inc.
Via
Business Wire
enGene to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
February 04, 2026
From
enGene Holdings Inc.
Via
Business Wire
enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc.
January 20, 2026
From
enGene Holdings Inc.
Via
Business Wire
enGene Reports Full Year 2025 Financial Results and Provides Business Update
December 22, 2025
From
enGene Holdings Inc.
Via
Business Wire
enGene’s Detalimogene Selected for FDA Manufacturing Pilot Program to Support Manufacturing Readiness
December 02, 2025
From
enGene Holdings Inc.
Via
Business Wire
enGene to Present at the Piper Sandler 37th Annual Healthcare Conference
November 25, 2025
From
enGene Holdings Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
November 18, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
November 13, 2025
Via
Benzinga
enGene Announces Pricing of $130 Million Public Offering of Common Shares and Pre-Funded Warrants
November 13, 2025
From
enGene Holdings Inc.
Via
Business Wire
enGene Announces Proposed Public Offering of Common Shares
November 12, 2025
From
enGene Holdings Inc.
Via
Business Wire
Top movers analysis one hour before the close of the markets on 2025-11-11: top gainers and losers in today's session.
↗
November 11, 2025
Via
Chartmill
Let's take a look at the stocks that are in motion in today's session.
↗
November 11, 2025
Via
Chartmill
Dow Gains More Than 300 Points; Energy Vault Holdings Shares Jump
↗
November 11, 2025
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
November 11, 2025
Via
Benzinga
EnGene Encouraged By Promising Response Rates In Bladder Cancer Trial
↗
November 11, 2025
Via
Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session.
↗
November 11, 2025
Via
Chartmill
Frequently Asked Questions
Is enGene Therapeutics Inc. - Common Stock publicly traded?
Yes, enGene Therapeutics Inc. - Common Stock is publicly traded.
What exchange does enGene Therapeutics Inc. - Common Stock trade on?
enGene Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for enGene Therapeutics Inc. - Common Stock?
The ticker symbol for enGene Therapeutics Inc. - Common Stock is ENGN on the Nasdaq Stock Market
What is the current price of enGene Therapeutics Inc. - Common Stock?
The current price of enGene Therapeutics Inc. - Common Stock is 1.500
When was enGene Therapeutics Inc. - Common Stock last traded?
The last trade of enGene Therapeutics Inc. - Common Stock was at 05/08/26 04:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
wpDiscuz
Insert